Dr. Usman

Dr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson & Johnson and Sanofi.

Latest Articles by Dr. Usman

Modified GRF (1-29) and HGH Synthesis

Modified GRF (1-29) and HGH Synthesis

  Modified GRF (1-29) is a peptide hormone that is also known as CJC-1295 without DAC (Drug Affinity Complex). It is a synthetic analog of growth hormone-releasing hormone (GHRH) and is...

Potential Applications of the ARA-290 Peptide

Potential Applications of the ARA-290 Peptide

  ARA-290 peptide is a promising molecule that has recently gained attention. This small, synthetic peptide is a derivative of erythropoietin (EPO), a hormone that stimulates the production of...